These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 19176640)
1. BRG1 and LKB1: tales of two tumor suppressor genes on chromosome 19p and lung cancer. Rodriguez-Nieto S; Sanchez-Cespedes M Carcinogenesis; 2009 Apr; 30(4):547-54. PubMed ID: 19176640 [TBL] [Abstract][Full Text] [Related]
2. Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. Sanchez-Cespedes M; Parrella P; Esteller M; Nomoto S; Trink B; Engles JM; Westra WH; Herman JG; Sidransky D Cancer Res; 2002 Jul; 62(13):3659-62. PubMed ID: 12097271 [TBL] [Abstract][Full Text] [Related]
3. Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors. Medina PP; Carretero J; Fraga MF; Esteller M; Sidransky D; Sanchez-Cespedes M Genes Chromosomes Cancer; 2004 Oct; 41(2):170-7. PubMed ID: 15287030 [TBL] [Abstract][Full Text] [Related]
4. Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines. Medina PP; Romero OA; Kohno T; Montuenga LM; Pio R; Yokota J; Sanchez-Cespedes M Hum Mutat; 2008 May; 29(5):617-22. PubMed ID: 18386774 [TBL] [Abstract][Full Text] [Related]
5. Novel and natural knockout lung cancer cell lines for the LKB1/STK11 tumor suppressor gene. Carretero J; Medina PP; Pio R; Montuenga LM; Sanchez-Cespedes M Oncogene; 2004 May; 23(22):4037-40. PubMed ID: 15021901 [TBL] [Abstract][Full Text] [Related]
6. Genetic and epigenetic alterations of BRG1 promote oral cancer development. Gunduz E; Gunduz M; Ouchida M; Nagatsuka H; Beder L; Tsujigiwa H; Fukushima K; Nishizaki K; Shimizu K; Nagai N Int J Oncol; 2005 Jan; 26(1):201-10. PubMed ID: 15586241 [TBL] [Abstract][Full Text] [Related]
7. LKB1 mutation in large cell carcinoma of the lung. Zhong D; Guo L; de Aguirre I; Liu X; Lamb N; Sun SY; Gal AA; Vertino PM; Zhou W Lung Cancer; 2006 Sep; 53(3):285-94. PubMed ID: 16822578 [TBL] [Abstract][Full Text] [Related]
8. BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines. Wong AK; Shanahan F; Chen Y; Lian L; Ha P; Hendricks K; Ghaffari S; Iliev D; Penn B; Woodland AM; Smith R; Salada G; Carillo A; Laity K; Gupte J; Swedlund B; Tavtigian SV; Teng DH; Lees E Cancer Res; 2000 Nov; 60(21):6171-7. PubMed ID: 11085541 [TBL] [Abstract][Full Text] [Related]
9. Distinctive gene expression of human lung adenocarcinomas carrying LKB1 mutations. Fernandez P; Carretero J; Medina PP; Jimenez AI; Rodriguez-Perales S; Paz MF; Cigudosa JC; Esteller M; Lombardia L; Morente M; Sanchez-Verde L; Sotelo T; Sanchez-Cespedes M Oncogene; 2004 Jun; 23(29):5084-91. PubMed ID: 15077168 [TBL] [Abstract][Full Text] [Related]
10. Targeted knockout of BRG1 potentiates lung cancer development. Glaros S; Cirrincione GM; Palanca A; Metzger D; Reisman D Cancer Res; 2008 May; 68(10):3689-96. PubMed ID: 18483251 [TBL] [Abstract][Full Text] [Related]
11. Specific pattern of LKB1 and phospho-acetyl-CoA carboxylase protein immunostaining in human normal tissues and lung carcinomas. Conde E; Suarez-Gauthier A; García-García E; Lopez-Rios F; Lopez-Encuentra A; García-Lujan R; Morente M; Sanchez-Verde L; Sanchez-Cespedes M Hum Pathol; 2007 Sep; 38(9):1351-60. PubMed ID: 17521700 [TBL] [Abstract][Full Text] [Related]
12. The reversible epigenetic silencing of BRM: implications for clinical targeted therapy. Glaros S; Cirrincione GM; Muchardt C; Kleer CG; Michael CW; Reisman D Oncogene; 2007 Oct; 26(49):7058-66. PubMed ID: 17546055 [TBL] [Abstract][Full Text] [Related]
13. Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis. Reisman DN; Sciarrotta J; Wang W; Funkhouser WK; Weissman BE Cancer Res; 2003 Feb; 63(3):560-6. PubMed ID: 12566296 [TBL] [Abstract][Full Text] [Related]
14. Expression of LKB1 tumor suppressor in non-small cell lung cancer determines sensitivity to 2-deoxyglucose. Inge LJ; Coon KD; Smith MA; Bremner RM J Thorac Cardiovasc Surg; 2009 Mar; 137(3):580-6. PubMed ID: 19258070 [TBL] [Abstract][Full Text] [Related]
15. SWI/SNF complex is essential for NRSF-mediated suppression of neuronal genes in human nonsmall cell lung carcinoma cell lines. Watanabe H; Mizutani T; Haraguchi T; Yamamichi N; Minoguchi S; Yamamichi-Nishina M; Mori N; Kameda T; Sugiyama T; Iba H Oncogene; 2006 Jan; 25(3):470-9. PubMed ID: 16247481 [TBL] [Abstract][Full Text] [Related]
16. Frequent homozygous deletion of the LKB1/STK11 gene in non-small cell lung cancer. Gill RK; Yang SH; Meerzaman D; Mechanic LE; Bowman ED; Jeon HS; Roy Chowdhuri S; Shakoori A; Dracheva T; Hong KM; Fukuoka J; Zhang JH; Harris CC; Jen J Oncogene; 2011 Sep; 30(35):3784-91. PubMed ID: 21532627 [TBL] [Abstract][Full Text] [Related]
17. The role of LKB1 in lung cancer. Sanchez-Cespedes M Fam Cancer; 2011 Sep; 10(3):447-53. PubMed ID: 21516316 [TBL] [Abstract][Full Text] [Related]
18. LKB1 interacts with and phosphorylates PTEN: a functional link between two proteins involved in cancer predisposing syndromes. Mehenni H; Lin-Marq N; Buchet-Poyau K; Reymond A; Collart MA; Picard D; Antonarakis SE Hum Mol Genet; 2005 Aug; 14(15):2209-19. PubMed ID: 15987703 [TBL] [Abstract][Full Text] [Related]
19. The 3p21 candidate tumor suppressor gene BAF180 is normally expressed in human lung cancer. Sekine I; Sato M; Sunaga N; Toyooka S; Peyton M; Parsons R; Wang W; Gazdar AF; Minna JD Oncogene; 2005 Apr; 24(16):2735-8. PubMed ID: 15735765 [TBL] [Abstract][Full Text] [Related]